Altrova Health Enters US Market With Sale of 2,000 O-Spray Units

03:54 PM EDT, 10/19/2026 (MT Newswires) -- Altrova Health (ROVA.CN) said Monday it sold 2,000 units of its O-Spray product to a distributor of peptide products, marking its entry into the US market. O-Spray is a needle-free oral spray designed to deliver precise, consistent doses as an alternative to injections and pills, the company said. It added that it is building a network of distributors to expand sales across US and international healthcare and retail channels. "The company is also expanding its product pipeline in peptide-based health products for men's health, women's health, and pet health," it added. Shares of Altrova Health rose 11% to CA$0.05 at the Canadian Securities Exchange. Price: 0.05, Change: +0.01, Percent Change: +11.11